Page last updated: 2024-08-24

3,4,5,3',4'-pentachlorobiphenyl and Cirrhosis

3,4,5,3',4'-pentachlorobiphenyl has been researched along with Cirrhosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Deng, P; Hennig, B; Morris, AJ; Sexton, T; Wahlang, B; Wang, C1
Balamurugan, AN; Cave, MC; Chari, ST; Falkner, KC; Hardesty, JE; Jan, J; Mokshagundam, SP; Prough, RA; Shi, H1

Other Studies

2 other study(ies) available for 3,4,5,3',4'-pentachlorobiphenyl and Cirrhosis

ArticleYear
Co-exposure to PCB126 and PFOS increases biomarkers associated with cardiovascular disease risk and liver injury in mice.
    Toxicology and applied pharmacology, 2020, 12-15, Volume: 409

    Topics: Alkanesulfonic Acids; Animals; Biomarkers; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Environmental Pollutants; Fibrosis; Fluorocarbons; Liver; Male; Mice; Mice, Inbred C57BL; Polychlorinated Biphenyls; Risk; Thrombosis

2020
Polychlorinated biphenyl exposures differentially regulate hepatic metabolism and pancreatic function: Implications for nonalcoholic steatohepatitis and diabetes.
    Toxicology and applied pharmacology, 2019, 01-15, Volume: 363

    Topics: Animals; Aroclors; Diabetes Mellitus; Disease Models, Animal; Endocrine Disruptors; Fibrosis; Humans; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Pancreas; Phospholipases A2, Calcium-Independent; Polychlorinated Biphenyls

2019